Richard J Gibbons Selected Research

X-Linked Mental Retardation (Mental Retardation, X Linked)

1/2018	How to Tackle Challenging ChIP-Seq, with Long-Range Cross-Linking, Using ATRX as an Example.
9/2013	The chromatin remodeller ATRX: a repeat offender in human disease.
7/2011	Functional significance of mutations in the Snf2 domain of ATRX.
3/2009	Altered visual function and interneuron survival in Atrx knockout mice: inference for the human syndrome.
7/2007	Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX.
2/2005	The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard J Gibbons Research Topics

Disease

9	ATR-X syndrome 01/2022 - 02/2004
7	Thalassemia 01/2017 - 03/2004
6	Neoplasms (Cancer) 01/2019 - 01/2005
6	X-Linked Mental Retardation (Mental Retardation, X Linked) 01/2018 - 02/2005
4	alpha-Thalassemia 10/2019 - 02/2004
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2021 - 02/2005
3	Intellectual Disability (Idiocy) 10/2019 - 10/2010
2	Leukemia 11/2015 - 02/2004
2	Hemoglobinopathies 03/2011 - 01/2005
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2004 - 02/2004
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2018
1	Pontocerebellar Hypoplasia 05/2018
1	Glioma (Gliomas) 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Hemolysis 01/2017
1	Bone Marrow Failure Disorders 11/2015
1	Fanconi Anemia (Fanconi's Anemia) 11/2015
1	Sickle Cell Anemia (Hemoglobin S Disease) 06/2015
1	Anemia 06/2015
1	Carcinogenesis 10/2014
1	Hemolytic Anemia 03/2014
1	Rare Diseases (Rare Disease) 10/2012
1	Starvation 08/2012
1	Confusion (Bewilderment) 01/2005
1	Primary Myelofibrosis (Myelosclerosis) 01/2005

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 10/2019 - 02/2004
9	GlobinsIBA 01/2022 - 10/2010
9	ChromatinIBA 01/2022 - 03/2004
3	X-linked Nuclear ProteinIBA 01/2018 - 07/2007
3	Histones (Histone)IBA 01/2018 - 04/2005
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019 - 07/2015
2	DNA (Deoxyribonucleic Acid)IBA 11/2015 - 07/2015
2	Amino Acids FDA Link 08/2012 - 03/2004
2	HeterochromatinIBA 06/2011 - 02/2004
2	Hemoglobins (Hemoglobin)IBA 12/2010 - 01/2005
2	alpha-GlobinsIBA 01/2005 - 02/2004
1	NucleotidesIBA 01/2021
1	mRNA Cleavage and Polyadenylation FactorsIBA 05/2018
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2018
1	Histone ChaperonesIBA 01/2018
1	Histone DemethylasesIBA 01/2017
1	AldehydesIBA 11/2015
1	RNA (Ribonucleic Acid)IBA 11/2015
1	Hemoglobin EIBA 06/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2014
1	Transcription Factors (Transcription Factor)IBA 03/2014
1	erythroid Kruppel-like factorIBA 03/2014
1	Adenosine Triphosphate (ATP)IBA 09/2013
1	Biological ProductsIBA 10/2012
1	EnzymesIBA 04/2005
1	Core Binding Factors (Core-Binding Factor)IBA 01/2005
1	Hemoglobin HIBA 02/2004
1	Protein Isoforms (Isoforms)IBA 02/2004

Therapy/Procedure

1	Therapeutics 01/2017
1	Transcutaneous Electric Nerve Stimulation (TENS) 06/2015
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 06/2015